- Home
- IPSC vs BZFD Comparison
IPSC vs BZFD Comparison
Compare IPSC & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- BZFD
- Stock Information
- Founded
- IPSC 2019
- BZFD 2006
- Country
- IPSC United States
- BZFD United States
- Employees
- IPSC N/A
- BZFD N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- BZFD Movies/Entertainment
- Sector
- IPSC Health Care
- BZFD Consumer Discretionary
- Exchange
- IPSC Nasdaq
- BZFD Nasdaq
- Market Cap
- IPSC 58.1M
- BZFD 65.1M
- IPO Year
- IPSC 2021
- BZFD N/A
- Fundamental
- Price
- IPSC $0.54
- BZFD $1.73
- Analyst Decision
- IPSC Strong Buy
- BZFD
- Analyst Count
- IPSC 5
- BZFD 0
- Target Price
- IPSC $3.67
- BZFD N/A
- AVG Volume (30 Days)
- IPSC 551.0K
- BZFD 315.4K
- Earning Date
- IPSC 05-08-2025
- BZFD 05-12-2025
- Dividend Yield
- IPSC N/A
- BZFD N/A
- EPS Growth
- IPSC N/A
- BZFD N/A
- EPS
- IPSC N/A
- BZFD N/A
- Revenue
- IPSC $6,589,000.00
- BZFD $189,887,000.00
- Revenue This Year
- IPSC $833.10
- BZFD $89.62
- Revenue Next Year
- IPSC N/A
- BZFD $4.50
- P/E Ratio
- IPSC N/A
- BZFD N/A
- Revenue Growth
- IPSC 194.81
- BZFD N/A
- 52 Week Low
- IPSC $0.34
- BZFD $1.26
- 52 Week High
- IPSC $3.70
- BZFD $5.68
- Technical
- Relative Strength Index (RSI)
- IPSC 53.48
- BZFD 37.09
- Support Level
- IPSC $0.34
- BZFD $1.65
- Resistance Level
- IPSC $0.54
- BZFD $1.79
- Average True Range (ATR)
- IPSC 0.05
- BZFD 0.15
- MACD
- IPSC 0.02
- BZFD -0.02
- Stochastic Oscillator
- IPSC 93.95
- BZFD 15.25
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.